aluates Reports

$ 0.0

Automative

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-23F5603

Global Breast Cancer Molecular Diagnostics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Code: QYRE-Auto-23F5603

Report

February 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Qiagen NV

Illumina Inc

Abbott

Oncotypeiq

Tellgen

Genetech

Gpmedical

Zeesan

Sansure

Breast Cancer Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Breast Cancer Molecular Diagnostics Market

A molecular approach for women to diagnose breast cancer

The global Breast Cancer Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Breast Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Molecular Diagnostics.

Report Scope

The Breast Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Breast Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Breast Cancer Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Breast Cancer Molecular Diagnostics Market
CAGR	5%
Segment by Type	PCR FISH DNA Sequencing Gene Chip
Segment by Application	Clinical Diagnosis Drug Screening Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Qiagen, Illumina, Abbott, Oncotypeiq, BD, Tellgen, Genetech, Gpmedical, Zeesan, Sansure
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Breast Cancer Molecular Diagnostics Market report?

Ans: The main players in the Breast Cancer Molecular Diagnostics Market are Roche, Qiagen, Illumina, Abbott, Oncotypeiq, BD, Tellgen, Genetech, Gpmedical, Zeesan, Sansure

What are the Application segmentation covered in the Breast Cancer Molecular Diagnostics Market report?

Ans: The Applications covered in the Breast Cancer Molecular Diagnostics Market report are Clinical Diagnosis, Drug Screening, Research

What are the Type segmentation covered in the Breast Cancer Molecular Diagnostics Market report?

Ans: The Types covered in the Breast Cancer Molecular Diagnostics Market report are PCR, FISH, DNA Sequencing, Gene Chip

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Breast Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 PCR

1.2.3 FISH

1.2.4 DNA Sequencing

1.2.5 Gene Chip

1.3 Market by Application

1.3.1 Global Breast Cancer Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.3.4 Research

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Breast Cancer Molecular Diagnostics Market Perspective (2019-2030)

2.2 Breast Cancer Molecular Diagnostics Growth Trends by Region

2.2.1 Global Breast Cancer Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Breast Cancer Molecular Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Breast Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Breast Cancer Molecular Diagnostics Market Dynamics

2.3.1 Breast Cancer Molecular Diagnostics Industry Trends

2.3.2 Breast Cancer Molecular Diagnostics Market Drivers

2.3.3 Breast Cancer Molecular Diagnostics Market Challenges

2.3.4 Breast Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Breast Cancer Molecular Diagnostics Players by Revenue

3.1.1 Global Top Breast Cancer Molecular Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Breast Cancer Molecular Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Breast Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Breast Cancer Molecular Diagnostics Revenue

3.4 Global Breast Cancer Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Breast Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Molecular Diagnostics Revenue in 2023

3.5 Breast Cancer Molecular Diagnostics Key Players Head office and Area Served

3.6 Key Players Breast Cancer Molecular Diagnostics Product Solution and Service

3.7 Date of Enter into Breast Cancer Molecular Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Molecular Diagnostics Breakdown Data by Type

4.1 Global Breast Cancer Molecular Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030)

5 Breast Cancer Molecular Diagnostics Breakdown Data by Application

5.1 Global Breast Cancer Molecular Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Breast Cancer Molecular Diagnostics Market Size (2019-2030)

6.2 North America Breast Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024)

6.4 North America Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Breast Cancer Molecular Diagnostics Market Size (2019-2030)

7.2 Europe Breast Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024)

7.4 Europe Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Breast Cancer Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Breast Cancer Molecular Diagnostics Market Size (2019-2030)

9.2 Latin America Breast Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Breast Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Breast Cancer Molecular Diagnostics Introduction

11.1.4 Roche Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Qiagen

11.2.1 Qiagen Company Detail

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Breast Cancer Molecular Diagnostics Introduction

11.2.4 Qiagen Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.2.5 Qiagen Recent Development

11.3 Illumina

11.3.1 Illumina Company Detail

11.3.2 Illumina Business Overview

11.3.3 Illumina Breast Cancer Molecular Diagnostics Introduction

11.3.4 Illumina Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.3.5 Illumina Recent Development

11.4 Abbott

11.4.1 Abbott Company Detail

11.4.2 Abbott Business Overview

11.4.3 Abbott Breast Cancer Molecular Diagnostics Introduction

11.4.4 Abbott Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.4.5 Abbott Recent Development

11.5 Oncotypeiq

11.5.1 Oncotypeiq Company Detail

11.5.2 Oncotypeiq Business Overview

11.5.3 Oncotypeiq Breast Cancer Molecular Diagnostics Introduction

11.5.4 Oncotypeiq Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.5.5 Oncotypeiq Recent Development

11.6 BD

11.6.1 BD Company Detail

11.6.2 BD Business Overview

11.6.3 BD Breast Cancer Molecular Diagnostics Introduction

11.6.4 BD Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.6.5 BD Recent Development

11.7 Tellgen

11.7.1 Tellgen Company Detail

11.7.2 Tellgen Business Overview

11.7.3 Tellgen Breast Cancer Molecular Diagnostics Introduction

11.7.4 Tellgen Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.7.5 Tellgen Recent Development

11.8 Genetech

11.8.1 Genetech Company Detail

11.8.2 Genetech Business Overview

11.8.3 Genetech Breast Cancer Molecular Diagnostics Introduction

11.8.4 Genetech Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.8.5 Genetech Recent Development

11.9 Gpmedical

11.9.1 Gpmedical Company Detail

11.9.2 Gpmedical Business Overview

11.9.3 Gpmedical Breast Cancer Molecular Diagnostics Introduction

11.9.4 Gpmedical Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.9.5 Gpmedical Recent Development

11.10 Zeesan

11.10.1 Zeesan Company Detail

11.10.2 Zeesan Business Overview

11.10.3 Zeesan Breast Cancer Molecular Diagnostics Introduction

11.10.4 Zeesan Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.10.5 Zeesan Recent Development

11.11 Sansure

11.11.1 Sansure Company Detail

11.11.2 Sansure Business Overview

11.11.3 Sansure Breast Cancer Molecular Diagnostics Introduction

11.11.4 Sansure Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024)

11.11.5 Sansure Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Qiagen NV

Illumina Inc

Abbott

Oncotypeiq

Tellgen

Genetech

Gpmedical

Zeesan

Sansure

List of Tables

Table 1. Global Breast Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PCR

Table 3. Key Players of FISH

Table 4. Key Players of DNA Sequencing

Table 5. Key Players of Gene Chip

Table 6. Global Breast Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Breast Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Breast Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Breast Cancer Molecular Diagnostics Market Share by Region (2019-2024)

Table 10. Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Breast Cancer Molecular Diagnostics Market Share by Region (2025-2030)

Table 12. Breast Cancer Molecular Diagnostics Market Trends

Table 13. Breast Cancer Molecular Diagnostics Market Drivers

Table 14. Breast Cancer Molecular Diagnostics Market Challenges

Table 15. Breast Cancer Molecular Diagnostics Market Restraints

Table 16. Global Breast Cancer Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Breast Cancer Molecular Diagnostics Market Share by Players (2019-2024)

Table 18. Global Top Breast Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Molecular Diagnostics as of 2023)

Table 19. Ranking of Global Top Breast Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Breast Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Breast Cancer Molecular Diagnostics Product Solution and Service

Table 23. Date of Enter into Breast Cancer Molecular Diagnostics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Breast Cancer Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Type (2019-2024)

Table 27. Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Type (2025-2030)

Table 29. Global Breast Cancer Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Application (2019-2024)

Table 31. Global Breast Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Breast Cancer Molecular Diagnostics Revenue Market Share by Application (2025-2030)

Table 33. North America Breast Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Breast Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Breast Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Roche Company Detail

Table 49. Roche Business Overview

Table 50. Roche Breast Cancer Molecular Diagnostics Product

Table 51. Roche Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Qiagen Company Detail

Table 54. Qiagen Business Overview

Table 55. Qiagen Breast Cancer Molecular Diagnostics Product

Table 56. Qiagen Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 57. Qiagen Recent Development

Table 58. Illumina Company Detail

Table 59. Illumina Business Overview

Table 60. Illumina Breast Cancer Molecular Diagnostics Product

Table 61. Illumina Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 62. Illumina Recent Development

Table 63. Abbott Company Detail

Table 64. Abbott Business Overview

Table 65. Abbott Breast Cancer Molecular Diagnostics Product

Table 66. Abbott Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 67. Abbott Recent Development

Table 68. Oncotypeiq Company Detail

Table 69. Oncotypeiq Business Overview

Table 70. Oncotypeiq Breast Cancer Molecular Diagnostics Product

Table 71. Oncotypeiq Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 72. Oncotypeiq Recent Development

Table 73. BD Company Detail

Table 74. BD Business Overview

Table 75. BD Breast Cancer Molecular Diagnostics Product

Table 76. BD Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 77. BD Recent Development

Table 78. Tellgen Company Detail

Table 79. Tellgen Business Overview

Table 80. Tellgen Breast Cancer Molecular Diagnostics Product

Table 81. Tellgen Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 82. Tellgen Recent Development

Table 83. Genetech Company Detail

Table 84. Genetech Business Overview

Table 85. Genetech Breast Cancer Molecular Diagnostics Product

Table 86. Genetech Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 87. Genetech Recent Development

Table 88. Gpmedical Company Detail

Table 89. Gpmedical Business Overview

Table 90. Gpmedical Breast Cancer Molecular Diagnostics Product

Table 91. Gpmedical Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 92. Gpmedical Recent Development

Table 93. Zeesan Company Detail

Table 94. Zeesan Business Overview

Table 95. Zeesan Breast Cancer Molecular Diagnostics Product

Table 96. Zeesan Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 97. Zeesan Recent Development

Table 98. Sansure Company Detail

Table 99. Sansure Business Overview

Table 100. Sansure Breast Cancer Molecular Diagnostics Product

Table 101. Sansure Revenue in Breast Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 102. Sansure Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Breast Cancer Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Breast Cancer Molecular Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. PCR Features

Figure 4. FISH Features

Figure 5. DNA Sequencing Features

Figure 6. Gene Chip Features

Figure 7. Global Breast Cancer Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Breast Cancer Molecular Diagnostics Market Share by Application: 2023 VS 2030

Figure 9. Clinical Diagnosis Case Studies

Figure 10. Drug Screening Case Studies

Figure 11. Research Case Studies

Figure 12. Breast Cancer Molecular Diagnostics Report Years Considered

Figure 13. Global Breast Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Breast Cancer Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Breast Cancer Molecular Diagnostics Market Share by Region: 2023 VS 2030

Figure 16. Global Breast Cancer Molecular Diagnostics Market Share by Players in 2023

Figure 17. Global Top Breast Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Molecular Diagnostics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Breast Cancer Molecular Diagnostics Revenue in 2023

Figure 19. North America Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Breast Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 21. United States Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Breast Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 25. Germany Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Breast Cancer Molecular Diagnostics Market Share by Region (2019-2030)

Figure 33. China Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Breast Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 41. Mexico Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Breast Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 45. Turkey Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Breast Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 48. Qiagen Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 49. Illumina Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 50. Abbott Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 51. Oncotypeiq Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 52. BD Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 53. Tellgen Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 54. Genetech Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 55. Gpmedical Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 56. Zeesan Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 57. Sansure Revenue Growth Rate in Breast Cancer Molecular Diagnostics Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions